<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1609200152
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Dotagraf 0.5 mmol/ml Solution for Injection
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GADOTERIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mmol/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        59.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Headquarter Sanochemia Pharmazeutika AG" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Headquarter Sanochemia Pharmazeutika AG
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2947]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Bayer Saudi Arabia
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAYER AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        V08CA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dotagraf is a contrast agent that contains gadoteric acid. It is for<br />diagnostic use only.<br />Dotagraf is used to enhance the contrast of the images obtained in<br />examinations with Magnetic Resonance Imaging (MRI). This contrast<br />enhancement improves the visualisation and delineation in:<br />Adult and paediatric population (0 - 18 years)<br />MRI of the Central Nervous System including defects (lesions) in<br />brain, spinal cord and adjacent tissue;<br />Whole body MRI including defects (lesions) in liver, kidneys,<br />pancreas, pelvis, lungs, heart, breast and musculoskeletal system.<br />Adult population<br />MR angiography including defects (lesions) and narrowing<br />(stenosis) in arteries, except in coronary arteries.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You should NOT be given Dotagraf<br />if you are allergic to the active substance or any of the other<br />ingredients of this medicine (listed in section 6).<br />if you are allergic to medicines containing gadolinium (like other<br />contrast agents used for magnetic resonance imaging).<br />Warnings and precautions<br />Inform your doctor or radiologist if the following applies to you:<br />RRyou have previously reacted to a contrast agent during an<br />examination<br />you have asthma<br />you have a history of allergy (such as seafood allergy, urticaria,<br />hay fever)<br />you are being treated with a beta-blocker (medicine for heart and<br />blood pressure disorders, such as metoprolol)<br />your kidneys do not work properly<br />you have recently had, or soon expect to have, a liver transplant<br />you have a disease affecting your heart or your blood vessels<br />you have had convulsions or you are being treated for epilepsy.<br />In all these cases, your doctor or radiologist will assess the benefitto-<br />risk ratio and decide whether you should be given Dotagraf.<br />If you are given Dotagraf, your doctor or radiologist will take the<br />precautions necessary and the administration of Dotagraf will be<br />carefully monitored.<br />Your doctor or radiologist may decide to take a blood test to check<br />how well your kidneys are working before making the decision to use<br />Dotagraf, especially if you are 65 years of age or older.<br />Neonates and infants<br />As kidney function is immature in babies up to 4 weeks of age and<br />infants up to 1 year of age, Dotagraf will only be used in these<br />patients after careful consideration by the doctor.<br />Remove all metallic objects you may wear before the examination.<br />Inform your doctor or radiologist if you have:<br />a pacemaker<br />a vascular clip<br />an infusion pump<br />a nerve stimulator<br />a cochlear implant (implant in the inner ear)<br />any suspected metallic foreign bodies, particularly in the eye.<br />This is important as these can result in serious problems, as<br />magnetic resonance imaging devices use very strong magnetic fields.<br />Other medicines and Dotagraf<br />Tell your doctor or radiologist if you are taking, have recently taken<br />or might take any other medicines. In particular, please inform your<br />doctor, radiologist or pharmacist if you are taking or have recently<br />taken medicines for heart and blood pressure disorders such as<br />beta-blocking agents, vasoactive substances, angiotensin-converting<br />enzyme inhibitors, angiontensin II receptor antagonists.<br />Dotagraf with food and drink<br />There are no known interactions between Dotagraf and food<br />and drinks. However, please check with your doctor, radiologist<br />or pharmacist if it is required not to eat or drink before the<br />examination.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or<br />are planning to have a baby, ask your doctor or radiologist for advice<br />before taking this medicine.<br />Pregnancy<br />Dotagraf should not be used during pregnancy unless strictly<br />necessary.<br />Breast-feeding<br />Your doctor or radiologist will discuss whether you should continue<br />breast-feeding or interrupt breast-feeding for a period of 24 hours<br />after you receive Dotagraf.<br />Driving and using machines<br />No data are available on the effects of Dotagraf on the ability to<br />drive. If you feel unwell after the examination, you should not drive<br />or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dotagraf will be administered to you by intravenous injection.<br />During the examination, you will be under the supervision of a<br />doctor or radiologist. A needle will be left in your vein; this will allow<br />the doctor or radiologist to inject you with appropriate emergency<br />drugs if necessary. If you experience an allergic reaction, the<br />administration of Dotagraf will be stopped.<br />Dotagraf can be administered by hand or by the mean of an<br />automatic injector. In neonates and infants, the product will only be<br />administered by hand.<br />The procedure will be carried out in a hospital, clinic or private<br />practice. The attending staff know what precautions have to be<br />taken for the examination. They are also aware of the possible<br />complications that can occur.<br />Dosage<br />Your doctor or radiologist will determine the dose you will receive<br />and supervise the injection.<br />Dosage in special patient groups<br />The use of Dotagraf is not recommended in patients with severe<br />kidney problems and patients who have recently had, or soon expect<br />to have, a liver transplant. However if use is required you should<br />only receive one dose of Dotagraf during a scan and you should not<br />receive a second injection for at least 7 days.<br />Neonates, infants, children and adolescents<br />As kidney function is immature in babies up to 4 weeks of age and<br />infants up to 1 year of age, Dotagraf will only be used in these<br />patients after careful consideration by the doctor. Neonates and<br />infants should only receive one dose of Dotagraf during a scan and<br />should not receive a second injection for at least 7 days.<br />Use for angiography is not recommended in children less than 18<br />years of age.<br />Elderly<br />It is not necessary to adjust your dose if you are 65 years of age or<br />older but you may have a blood test to check how well your kidneys<br />are working.<br />If too much Dotagraf has been administered to you<br />It is highly unlikely that you will be given an overdose. You will<br />be given Dotagraf in a medical setting by a trained person. In the<br />real case of overdose, Dotagraf can be removed from the body by<br />haemodialysis (blood cleaning).<br />Additional information regarding the use and handling by the<br />medical or healthcare professional is given at the end of this leaflet.<br />If you have any further questions on the use of this medicine, ask<br />your doctor or radiologist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not<br />everybody gets them.<br />After the administration, you will be kept under observation for at<br />least half an hour. Most side effects occur immediately or sometimes<br />delayed. Some effects can occur up to seven days after Dotagraf<br />injection.<br />There is a small risk that you may have an allergic reaction to<br />Dotagraf. Such reactions can be severe and result in shock (case<br />of allergic reaction that could put your life in danger). The following<br />symptoms may be the first signs of a shock. Inform immediately<br />your doctor, radiologist or health professional if you feel any of<br />them:<br />swelling of the face, mouth or throat which may cause you<br />difficulties in swallowing or breathing<br />swelling of hands or feet<br />lightheadedness (low blood pressure)<br />breathing difficulties<br />whistling respiration<br />coughing<br />itching<br />runny nose<br />sneezing<br />eye irritation<br />hives<br />skin rash<br />Uncommon side effects (may affect up to 1 in 100 people)<br />hypersensitivity (allergic reaction)<br />headaches<br />unusual taste in the mouth<br />dizziness<br />somnolence (sleepiness)<br />sensation of tinglings, warmth/burning, cold and/or pain<br />low or high blood pressure<br />nausea (feeling sick)<br />stomach pain<br />rash<br />feeling hot, feeling cold<br />asthenia (loss of energy; weakness)<br />injection site discomfort, injection site reaction, injections site<br />coldness, injection site swelling, diffusion of the product outside<br />of blood vessels that can lead to inflammation (redness and local<br />pain)<br />Rare side effects (may affect up to 1 in 1,000 people)<br />anxiety, faintness (dizziness and feeling of imminent loss of<br />consciousness)<br />eyelid swelling<br />palpitations<br />sneezing<br />vomiting (being sick)<br />diarrhea<br />increased saliva secretion<br />hives, itching, sweating<br />chest pain, chills<br />Very rare side effects: (may affect up to 1 in 10,000 people)<br />anaphylactic or anaphylactic-like reactions (a serious, potentially<br />life-threatening allergic reaction)<br />agitation<br />coma, seizures, syncope (brief loss of consciousness), disorder of<br />smell (perception of often unpleasant odours), tremor<br />conjunctivitis, red eye, blurred vision, increased tear secretion<br />cardiac arrest, accelerated or slow heart beat, irregular heart beat,<br />vascular dilatation, pallor<br />respiratory arrest, pulmonary oedema, breathing difficulties,<br />wheezing, stuffy nose, cough, dry throat, throat constriction with<br />feeling of suffocation, respiratory spasms, throat swelling<br />eczema, redness of the skin, swelling of the lips and localized in<br />the mouth<br />muscle cramps, muscle weakness, back pain<br />malaise, chest discomfort, fever, swelling of the face, diffusion of<br />the product outside of blood vessels that can lead to tissue dying<br />off at the injection site, inflammation of a vein<br />decrease in oxygen level in blood<br />There have been reports of nephrogenic systemic fibrosis (which<br />causes hardening of the skin and may affect also soft tissue and<br />internal organs), most of which were in patients who received<br />Dotagraf together with other gadolinium-containing contrast<br />agents. If, during the weeks following the MRI examination, you<br />notice changes in the colour and/or thickness of your skin in<br />any part of your body, inform the radiologist who performed the<br />examination.<br />Reporting of side effects<br />If you get any side effects, talk to your radiologist, pharmacist,<br />doctor or nurse. This includes any possible side effects not listed<br />in this leaflet. By reporting side effects you can help provide more<br />information on the safety of this medicine.<br />To report any side effect(s):<br />The National Pharmacovigilance Centre (NPC).<br />Fax: +966-11-205-7662<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Store below 30&deg;C .<br />Chemical and physical in-use stability has been demonstrated<br />72 hours at room temperature. From a microbiological point<br />of view, the product should be used immediately. If not used<br />immediately, in-use storage times and conditions prior to use are the<br />responsibility of the user and would normally not be longer that 24<br />hours at 2 to 8 &deg;C, unless opening has taken place in controlled and<br />validated aseptic conditions.<br />Do not use this medicine after the expiry date which is stated on the<br />vial and on the carton, after the abbreviation &ldquo;Exp&rdquo;. The expiry date<br />refers to the last day of that month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Dotagraf contains<br />The active substance is gadoteric acid. One millilitre of solution<br />for injection contains 279.32 mg of gadoteric acid (as meglumine<br />salt), equivalent to 0.5 mmol of gadoteric acid (as meglumine<br />salt).<br />The other ingredients are meglumine,<br />1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)<br />and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Dotagraf looks like and contents of the pack
Dotagraf is a clear, colourless to yellow solution for intravenous
injection.
The Dotagraf pack contains one or ten vials with 10, 15 and 20 ml of
solution for injection.
Not all pack sizes may be marketed
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufacturer:<br />Sanochemia Pharmazeutika AG<br />Landeggerstrasse 7<br />2491 Neufeld/Leitha, Austria.</p><p>Marketing Authorisation Holder<br />Bayer AG<br />Kaiser-Wilhelm-Allee 1<br />51373 Leverkusen, Germany.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in October, 2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:right">دوتاجراف هو عامل تباين يحتوي على حمض جادوتيريك. مستحضر طبي يستخدم فقط للتشخيص.</p><p dir="RTL" style="text-align:right">يستخدم دوتاجراف لكي يزيد من شدة تباين الصور التي يتم الحصول عليها في الفحص باستخدام التصوير بالرنين المغناطيسي. هذه الزيادة في شدة التباين تسبب تحسين في جودة التجسيد البصري والرسم التصويري في الحالات الآتية:</p><p dir="RTL" style="text-align:right"><em>لدى المرضى البالغين والأطفال (الفئة العمرية من صفر &ndash; 18 سنة من العمر)</em></p><p dir="RTL" style="text-align:right">التصوير بالرنين المغناطيسي للجهاز العصبي المركزي بما في ذلك العيوب (إصابة أو تلف أي جزء) في الدماغ، الحبل الشوكي والأنسجة المجاورة؛</p><p dir="RTL" style="text-align:right">التصوير بالرنين المغناطيسي للجسم كله بما في ذلك العيوب (إصابة أو تلف أي جزء) في الكبد، الكلى، البنكرياس، الحوض، الرئتين، القلب، الثدي والجهاز العضلي الهيكلي.</p><p dir="RTL" style="text-align:right"><em>المرضى البالغين</em></p><p>التصوير بالرنين المغناطيسي للأوعية الدموية بما في ذلك العيوب (إصابة أو تلف أي جزء) وضيق (ينشأ التضييق بسبب انسداد داخلي أو ضغط خارجي) في الشرايين، ما عدا في الشرايين التاجية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>يجب <u>عدم</u> استخدام دوتاجراف في الحالات الآتية</strong></p><p dir="RTL" style="text-align:right">إذا كان لديك حساسية من المادة الفعالة أو من أي من المكونات الأخرى لهذا الدواء (المذكورة في الجزء 6).</p><p dir="RTL" style="text-align:right">إذا كان لديك حساسية من الأدوية التي تحتوي على الجادولينيوم (مثل عوامل التباين الأخرى المستخدمة للتصوير بالرنين المغناطيسي).</p><p dir="RTL" style="text-align:right"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL" style="text-align:right">أخبر طبيبك أو أخصائي الأشعة إذا كان ما يلي ينطبق عليك:</p><p dir="RTL" style="text-align:right">كنت قد عانيت في الماضي من تفاعلات أثناء الفحص باستخدام عامل تباين</p><p dir="RTL" style="text-align:right">مصاب بمرض الربو الشعبي</p><p dir="RTL" style="text-align:right">لديك تاريخ مرضي من الحساسية (مثل حساسية المأكولات البحرية، بقع جلدية حمراء اللون مرتفعة عن سطح الجلد شديدة الحكة، فقاعات وبثور حمراء كبيرة تظهر على الجلد)</p><p dir="RTL" style="text-align:right">كنت تعالج بحاصرات بيتا (دواء لاضطرابات القلب وضغط الدم، مثل ميتوبرولول)</p><p dir="RTL" style="text-align:right">الكلى لديك لا تعمل بشكل صحيح</p><p dir="RTL" style="text-align:right">تم إجراء عملية زرع كبد لك حديثاً، أو تتوقع قريباً أن يتم إجراء عملية زرع كبد لك</p><p dir="RTL" style="text-align:right">لديك مرض يؤثر على القلب أو الأوعية الدموية</p><p dir="RTL" style="text-align:right">كنت تعاني من تشنجات أو كنت تعالج من الصرع.</p><p dir="RTL" style="text-align:right">في كل هذه الحالات، سيقوم طبيبك أو أخصائي الأشعة بتقييم نسبة الفائدة إلى نسبة المخاطرة وتحديد ما إذا كان بامكانك استخدام دوتاجراف. إذا تم إعطاؤك دوتاجراف، فإن طبيبك أو أخصائي الأشعة سيتخذ الاحتياطات اللازمة وسيتم مراقبة حالتك الطبية بعناية أثناء فترة استخدامك دوتاجراف.</p><p dir="RTL" style="text-align:right">قد يقرر طبيبك أو أخصائي الأشعة إجراء فحص دم للتحقق من مدى كفاءة كليتيك قبل اتخاذ قرار استخدام دوتاجراف، خاصة إذا كان عمرك 65 سنة أو أكثر.</p><p dir="RTL" style="text-align:right"><strong>الأطفال حديثي الولادة والرضع</strong></p><p dir="RTL" style="text-align:right">بما أن وظيفة الكلى غير ناضجة لدى الأطفال حديثي الولادة حتى عمر 4 أسابيع والأطفال الرضع حتى سن سنة واحدة، فإنه سيستخدم دوتاجراف فقط في هؤلاء المرضى بعد دراسة متأنية من الطبيب المعالج.</p><p dir="RTL" style="text-align:right">قم بإزالة جميع الأشياء المعدنية التي قد ترتديها قبل الفحص. أخبر طبيبك أو أخصائي الأشعة إذا كان لديك:</p><p dir="RTL" style="text-align:right">جهاز تنظيم ضربات القلب</p><p dir="RTL" style="text-align:right">مشبك أوعية دموية</p><p dir="RTL" style="text-align:right">مضخة تسريب للحقن</p><p dir="RTL" style="text-align:right">محفز للعصب</p><p dir="RTL" style="text-align:right">زرع قوقعة (غرس في الأذن الداخلية)</p><p dir="RTL" style="text-align:right">أي أجسام معدنية غريبة مشتبه بها، خاصة في العين.</p><p dir="RTL" style="text-align:right">هذا مهم، لأن هذه المستلزمات الطبية يمكن أن تؤدي إلى مشاكل خطيرة، حيث أن أجهزة التصوير بالرنين المغناطيسي تستخدم حقول مغناطيسية قوية جداً.</p><p dir="RTL" style="text-align:right"><strong>استخدام أدوية أخرى مع دوتاجراف</strong></p><p dir="RTL" style="text-align:right">أخبر طبيبك أو أخصائي الأشعة إذا كنت تستخدم، أو استخدمت أو قد تستخدم أي أدوية أخرى. على وجه الخصوص، يرجى إبلاغ الطبيب أو أخصائي الأشعة أو الصيدلي إذا كنت تستخدم أو استخدمت مؤخراً أدوية لاضطرابات القلب وضغط الدم مثل أدوية من المجموعة الدوائية حاصرات مستقبلات بيتا، مواد لها فاعلية على الأوعية الدموية، أدوية من المجموعة الدوائية مثبط الإنزيم المحول للأنجيوتنسين، أدوية من المجموعة الدوائية حاصرات مستقبلات الأنجيوتنسين 2.</p><p dir="RTL" style="text-align:right"><strong>استخدام دوتاجراف مع الطعام والمشروبات</strong></p><p dir="RTL" style="text-align:right">لا توجد تفاعلات معروفة بين دوتاجراف والطعام والمشروبات. مع ذلك، يرجى مراجعة طبيبك أو أخصائي الأشعة أو الصيدلي إذا كان مطلوباً منك عدم تناول الطعام أو الشراب قبل الفحص.</p><p dir="RTL" style="text-align:right"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL" style="text-align:right">إذا كنت أثناء فترة الحمل أو أثناء فترة القيام بالرضاعة الطبيعية، احتمال أنكِ قد تكونين حاملاً أو تخططين لإنجاب طفل، اسألي طبيبك أو أخصائي الأشعة للحصول على المشورة قبل استخدام هذا الدواء.</p><p dir="RTL" style="text-align:right"><em>الحمل</em></p><p dir="RTL" style="text-align:right">لا ينبغي استخدام دوتاجراف أثناء فترة الحمل ما لم يكن ضرورياً ومُجبرة علي استخدامه.</p><p dir="RTL" style="text-align:right"><em>الرضاعة الطبيعية</em></p><p dir="RTL" style="text-align:right">ﺳﻮف ﻳﻨﺎﻗشك ﻃﺒﻴﺒﻚ أو أﺧﺼﺎﺋﻲ الأشعة ﻣﺎ إذا كان ﻳﻨﺒﻐﻲ ﻋﻠﻴﻚِ ﻣﻮاﺻﻠﺔ القيام بالرضاعة الطبيعية أو إﻳﻘﺎف القيام باﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﻴﻌﻴﺔ ﻟﻔﺘﺮة 24 ﺳﺎﻋﺔ ﺑﻌﺪ اﺳتخدام دوتاجراف.</p><p dir="RTL" style="text-align:right"><strong>قيادة السيارات واستخدام الآلات</strong></p><p dir="RTL" style="text-align:right">لا تتوفر بيانات حول تأثيرات دوتاجراف على القدرة على قيادة السيارات. إذا شعرت بتوعك (شعور عام بـعدم الارتياح أو الاضطراب واعتلال الصحة) بعد الفحص، يجب عليك عدم قيادة السيارة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">سيتم استخدام دوتاجراف عن طريق الحقن في الوريد.</p><p dir="RTL" style="text-align:right"><strong>أثناء الفحص</strong>، ستكون تحت إشراف طبيب أو أخصائي الأشعة. سيتم ترك إبرة في الوريد؛ هذا سيسمح للطبيب أو أخصائي الأشعة بحقن أدوية الطوارئ المناسبة إذا لزم الأمر. إذا عانيت من تفاعل الحساسية، سيتم إيقاف استخدام دوتاجراف.</p><p dir="RTL" style="text-align:right">يمكن استخدام دوتاجراف باليد أو عن طريق وسيلة حقن تلقائي. في حديثي الولادة والرضع، سيتم استخدام المستحضر باليد فقط.</p><p dir="RTL" style="text-align:right">سيتم استخدام المستحضر لإجراء الفحص في مستشفى، عيادة أو عيادة خاصة. يعرف أعضاء الفريق الطبي المشارك في إجراء الفحص ما هي الاحتياطات الواجب اتخاذها لإجراء الفحص. كما أنهم يدركون المضاعفات المحتملة التي يمكن أن تحدث.</p><p dir="RTL" style="text-align:right"><strong>الجرعة</strong></p><p dir="RTL" style="text-align:right">سيقوم طبيبك أو أخصائي الأشعة بتحديد الجرعة التي ستستخدم والإشراف على الحقن.</p><p dir="RTL" style="text-align:right"><strong>الجرعة التي يجب استخدامها لدى المجموعات الخاصة من المرضى</strong></p><p dir="RTL" style="text-align:right">لا ينصح باستخدام دوتاجراف في المرضى الذين يعانون من مشاكل حادة في الكلى والمرضى الذين تم إجراء لهم حديثاً عملية زرع كبد، أو تتوقع قريباً أن يتم إجراء لهم عملية زرع كبد. ولكن إذا كان استخدام دوتاجراف مطلوباً، يجب أن يتم استخدام جرعة واحدة فقط من دوتاجراف أثناء الفحص، ويجب عدم استخدام حقنة ثانية خلال مدة 7 أيام على الأقل.</p><p dir="RTL" style="text-align:right"><em>المرضى حديثي الولادة، الرضع، الأطفال والمراهقين</em></p><p dir="RTL" style="text-align:right">بما أن وظيفة الكلى غير ناضجة لدى الأطفال حديثي الولادة حتى عمر 4 أسابيع والأطفال الرضع حتى سن سنة واحدة، فإنه سيستخدم دوتاجراف فقط في هؤلاء المرضى بعد دراسة متأنية من الطبيب المعالج. يجب على الأطفال حديثي الولادة والأطفال الرضع استخدام جرعة واحدة فقط من دوتاجراف أثناء الفحص، ويجب عدم استخدام حقنة ثانية خلال مدة 7 أيام على الأقل.</p><p dir="RTL" style="text-align:right">لا يُنصح باستخدام دوتاجراف لتصوير الأوعية الدموية لدى الأطفال الأقل من 18 عاماً.</p><p dir="RTL" style="text-align:right"><em>كبار السن</em></p><p dir="RTL" style="text-align:right">ليس من الضروري تعديل الجرعة إذا كان عمرك 65 سنة أو أكثر، لكن قد يطلب منك طبيبك إجراء فحص دم للتأكد من كفاءة عمل الكليتين.</p><p dir="RTL" style="text-align:right"><strong>إذا تم استخدام جرعة زائدة من دوتاجراف</strong></p><p dir="RTL" style="text-align:right">من المستبعد جداً أن يتم استخدام جرعة زائدة. سيتم تحديد الجرعة المستخدمة من مستحضر دوتاجراف تحت إشراف طبي عن طريق شخص مدرب. في حالة استخدام جرعة زائدة، يمكن إزالة دوتاجراف من الجسم عن طريق غسيل الكلى (تنظيف الدم).</p><p dir="RTL" style="text-align:right">مذكور في نهاية هذه النشرة معلومات إضافية للمهن الطبية والمتخصصين في الرعاية الصحية عن استخدام دوتاجراف وطريقة التعامل مع المستحضر.</p><p dir="RTL" style="text-align:right">إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو أخصائي الأشعة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثاراً جانبية، على الرغم من عدم إصابة الجميع بها.</p><p dir="RTL" style="text-align:right"><strong>بعد استخدام المستحضر، </strong>ستظل تحت الملاحظة لمدة نصف ساعة على الأقل. معظم الآثار الجانبية تحدث على الفور أو تتأخر في بعض الأحيان. يمكن أن تحدث بعض الآثار الجانبية بعد مدة قد تصل إلى سبعة أيام بعد حقن دوتاجراف.</p><p dir="RTL" style="text-align:right"><strong>هناك مخاطرة صغيرة في أن يتم إصابتك بتفاعل حساسية من دوتاجراف. قد تكون تفاعلات الحساسية هذه شديدة وتؤدي إلى صدمة</strong> (حالة من الحساسية الشديدة قد تعرض حياتك للخطر). قد تكون الأعراض التالية هي العلامات الأولى للصدمة. أبلغ طبيبك، أخصائي الأشعة أو أحد من أفراد الفريق الطبي المتخصص فوراً إذا شعرت بأي منها:</p><p dir="RTL" style="text-align:right">تورم الوجه، الفم أو الحلق مما قد يسبب صعوبات في البلع أو التنفس</p><p dir="RTL" style="text-align:right">تورم اليدين أو القدمين</p><p dir="RTL" style="text-align:right">صداع مع دوار (انخفاض ضغط الدم)</p><p dir="RTL" style="text-align:right">صعوبات في التنفس</p><p dir="RTL" style="text-align:right">سماع صفير عند التنفس</p><p dir="RTL" style="text-align:right">السعال</p><p dir="RTL" style="text-align:right">حكة (إحساس مثير للجلد يسبب الرغبة في الخدش)</p><p dir="RTL" style="text-align:right">رشح الأنف</p><p dir="RTL" style="text-align:right">العطس</p><p dir="RTL" style="text-align:right">تهييج العين</p><p dir="RTL" style="text-align:right">فقاعات و بثور حمراء كبيرة تظهر على الجلد</p><p dir="RTL" style="text-align:right">طفح جلدي (احمرار أو بقع تظهر على الجلد)</p><p dir="RTL" style="text-align:right"><strong>آثار جانبية غير شائعة</strong>: (قد تصيب 1 من كل 100 مريض)</p><p dir="RTL" style="text-align:right">حساسية زائدة (تفاعل حساسية)</p><p dir="RTL" style="text-align:right">صداع</p><p dir="RTL" style="text-align:right">طعم غير عادي في الفم</p><p dir="RTL" style="text-align:right">دوخة</p><p dir="RTL" style="text-align:right">النعاس (كسلان)</p><p dir="RTL" style="text-align:right">الإحساس بالوخز، الدفء / الحرق، والبرد و / أو الألم</p><p dir="RTL" style="text-align:right">انخفاض أو ارتفاع ضغط الدم</p><p dir="RTL" style="text-align:right">الغثيان (الشعور بالغثيان)</p><p dir="RTL" style="text-align:right">ألم المعدة</p><p dir="RTL" style="text-align:right">طفح جلدي (تغيير الجلد الذي يؤثر على لونه أو مظهره أو قوامه)</p><p dir="RTL" style="text-align:right">الشعور بسخونة، الشعور ببرودة</p><p dir="RTL" style="text-align:right">فقدان القوة (فقدان الطاقة؛ الضعف)</p><p dir="RTL" style="text-align:right">اضطرابات في موقع الحقن، تفاعل في موقع الحقن، برودة في موقع الحقن، تورم في موقع الحقن، انتشار المستحضر خارج الأوعية الدموية الذي يمكن أن يؤدي إلى التهاب (احمرار وألم موضعي)</p><p dir="RTL" style="text-align:right"><strong>آثار جانبية نادرة</strong>: (قد تصيب 1 من كل 1,000 مريض)</p><p dir="RTL" style="text-align:right">القلق، الإغماء (الدوخة والشعور باحتمال فقدان الوعي في أي لحظة)</p><p dir="RTL" style="text-align:right">تورم جفون العين</p><p dir="RTL" style="text-align:right">خفقان القلب</p><p dir="RTL" style="text-align:right">العطس</p><p dir="RTL" style="text-align:right">القيء (غير سليم - مريض)</p><p dir="RTL" style="text-align:right">إسهال</p><p dir="RTL" style="text-align:right">زيادة إفراز اللعاب</p><p dir="RTL" style="text-align:right">فقاعات و بثور حمراء كبيرة تظهر على الجلد، حكة (إحساس مثير للجلد يسبب الرغبة في الخدش)، زيادة إفراز العرق،</p><p dir="RTL" style="text-align:right">ألم في الصدر، قشعريرة برد</p><p dir="RTL" style="text-align:right"><strong>آثار جانبية نادرة جداً</strong>: (قد تصيب 1 من كل 10000 مريض)</p><p dir="RTL" style="text-align:right">تفاعلات صدمة الحساسية أو تفاعلات تشبه صدمة الحساسية (تفاعل حساسية خطير، يحتمل أن يهدد الحياة)</p><p dir="RTL" style="text-align:right">هِياج (اضطراب حالة العقل أو المشاعر)،</p><p dir="RTL" style="text-align:right">غيبوبة، نوبات (تغييرات للنشاط الكهربائي في الدماغ)، الإغماء (فقدان قصير للوعي)، اضطراب الرائحة (إدراك الروائح الكريهة في كثير من الأحيان)، رعشه</p><p dir="RTL" style="text-align:right">التهاب باطن الجفن، عين حمراء، عدم وضوح الرؤية، زيادة إفراز الدموع</p><p dir="RTL" style="text-align:right">توقف القلب، تسريع أو بطء ضربات القلب، عدم انتظام ضربات القلب، توسع الأوعية الدموية، شحوب الوجه (فقدان الجلد للونه الطبيعي وميله إلى الأبيض أو الأصفر بحسب لون البشرة الأصلي)</p><p dir="RTL" style="text-align:right">توقف التنفس، وذمة رئوية (تراكم السوائل في الرئة)، صعوبات في التنفس، الصفير عند التنفس، انسداد الأنف، سعال، الحلق الجاف، انقباض الحلق مع الشعور بالاختناق، تشنجات تنفسية، تورم الحلق</p><p dir="RTL" style="text-align:right">الإكزيمة (شكل من أشكال التهاب الطبقات العليا من الجلد)، احمرار الجلد، تورم الشفاه ومحدد في منطقة الفم</p><p dir="RTL" style="text-align:right">تشنجات العضلات، ضعف العضلات، ألم في الظهر</p><p dir="RTL" style="text-align:right">توعك (شعور عام بـعدم الارتياح أو الاضطراب واعتلال الصحة)، عدم الراحة في الصدر، حمة (ارتفاع درجة حرارة الجسم)، انتفاخ الوجه، انتشار المستحضر خارج الأوعية الدموية التي يمكن أن ينتج عنه موت الأنسجة في مكان الحقن، التهاب الوريد</p><p dir="RTL" style="text-align:right">انخفاض في مستوى الأكسجين في الدم</p><p dir="RTL" style="text-align:right">كانت هناك تقارير عن التليف الكلوي النظامى المنشأ (الذي يسبب تصلب الجلد ويمكن أن يؤثر أيضاً على الأنسجة الرخوة والأعضاء الداخلية)، وكانت معظم هذه التقارير عن مرضى تم استخدامِهم لدوتاجراف في نفس الوقت مع عوامل تباين أخرى تحتوي على الجادولينيوم. فإذا لاحظت، خلال الأسابيع التالية للفحص باستخدام التصوير بالرنين المغناطيسي، تغيرات في لون و / أو سمك الجلد في أي جزء من جسمك، فأَخبر أخصائي الأشعة الذي أجرى الفحص.</p><p dir="RTL" style="text-align:right"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL" style="text-align:right">إذا تم إصابتك بأي آثار جانبية، تحدث إلى أخصائي الأشعة، الصيدلي، الطبيب أو الممرضة. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة. من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في تقديم المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL" style="text-align:right"><strong>للإبلاغ عن الأعراض الجانبية:</strong></p><p dir="RTL" style="text-align:right"><strong>المركز الوطني للتيقظ الدوائي</strong></p><p dir="RTL" style="text-align:right">فاكس: 7662 &ndash; 205 &ndash; 11 &ndash; 966 +</p><p dir="RTL" style="text-align:right">مركز اتصال الهيئة العامة للغذاء والدواء: 19999</p><p dir="RTL" style="text-align:right">البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL" style="text-align:right">الموقع الالكتروني: https://ade.sfda.gov.sa</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">يحفظ هذا الدواء بعيدا عن نظر ومتناول الأطفال.</p><p dir="RTL" style="text-align:right">يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL" style="text-align:right">تم إثبات الثبات الكيميائي والفيزيائي للمستحضر أثناء الاستخدام لمدة 72 ساعة في درجة حرارة الغرفة. من وجهة النظر الميكروبيولوجية، يجب استخدام هذا المستحضر على الفور. إذا لم يتم استخدام المستحضر على الفور، فإن أوقات وظروف التخزين المتبعة قبل استخدام المستحضر هي مسؤولية المستخدِم، ولن تكون عادة أطول من 24 ساعة في درجة حرارة تتراوح من 2 إلى 8 درجات مئوية، ما لم يتم فتحها في ظروف معقمة خاضعة للرقابة وتم التحقق من صحتها.</p><p>لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على القارورة (الفايل) وعلى العبوة الخارجية المصنوعة من الكرتون، والمكتوب بعد اختصار &laquo;Exp&raquo;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>ما الذي يحتوي عليه دوتاجراف</strong></p><p dir="RTL" style="text-align:right"><strong>المادة الفعالة</strong> هي حمض جادوتيريك. واحد ملليلتر من محلول الحقن يحتوي على 279.32 ملجم من حمض جادوتيريك (في شكل ملح الميجلومين)، مكافيئ إلى 0.5 مليمول من حمض جادوتيريك (في شكل ملح الميجلومين).</p><p><strong>المكونات الأخرى</strong> هي ميجلومين، 1، 4، 7، 10 &ndash; تترا أزا سيكلو دوديكان 1، 4، 7، 10- ثنائي أمين الإيثيلين رباعي حمض الأسيتيك(DOTA)&nbsp; وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>كيف يبدو دوتاجراف ومحتويات العبوة</strong></p><p dir="RTL" style="text-align:right">دوتاجراف محلول صافي (شفاف)، عديم اللون إلى أصفر للحقن في الوريد. تحتوي عبوة دوتاجراف على قارورة (فايل) واحدة أو على 10 قارورات (فايل)، والمستحضر متوفر بأحجام مختلفة 10 ، 15 و 20 مل من محلول للحقن.</p><p>قد لا يتم تسويق جميع أحجام العبوات</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>المصنع:</strong></p><p dir="RTL" style="text-align:right">سانوكيميا فارماسوتيكا ايه جي</p><p dir="RTL" style="text-align:right">7 لندججرستراسى</p><p dir="RTL" style="text-align:right">2491 نيوفلد / ليثا، النمسا</p><p dir="RTL" style="text-align:right"><strong>حامل ترخيص التسويق:</strong></p><p dir="RTL" style="text-align:right">باير ايه جي</p><p dir="RTL" style="text-align:right">1 طريق القيصر ويلهلم،</p><p dir="RTL" style="text-align:right">51373 ليفركوزن، ألمانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت أخر مراجعة لهذه النشرة في أكتوبر 2018.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dotagraf 0.5 mmol/ml solution for injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml solution for injection contains 279.32 mg gadoteric acid (as meglumine salt), equivalent to
0.5 mmol.
10 ml solution for injection contain 2793.2 mg gadoteric acid (as meglumine salt), equivalent to
5 mmol.
15 ml solution for injection contain 4189.8 mg gadoteric acid (as meglumine salt), equivalent to
7.5 mmol.
20 ml solution for injection contain 5586.4 mg gadoteric acid (as meglumine salt), equivalent to
10 mmol.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.
Clear, colourless to yellow solution.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product is for diagnostic use only.<br />Dotagraf is a contrast agent indicated for enhancement of the contrast in Magnetic Resonance Imaging<br />(MRI) for a better visualization/delineation in:<br />Adult and paediatric population (0-18 years)<br />&bull; MRI of the CNS including lesions of the brain, spine, and surrounding tissues<br />&bull; Whole body MRI including lesions of the liver, kidneys, pancreas, pelvis, lungs, heart, breast,<br />and musculoskeletal system.<br />Adult population<br />&bull; MR angiography including lesions or stenoses of the non-coronary arteries.<br />Dotagraf should be used only when diagnostic information is essential and not available with<br />unenhanced MRI.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />The lowest dose that provides sufficient enhancement for diagnostic purposes should be used. The<br />dose should be calculated based on the patient&rsquo;s body weight, and should not exceed the recommended<br />dose per kilogram of body weight detailed in this section.<br />Encephalic and spinal MRI<br />In neurological examinations, the dose can vary from 0.1 to 0.3 mmol/kg BW, corresponding to<br />0.2 to 0.6 ml/kg BW. After administration of 0.1 mmol/kg BW to patients with brain tumors, the<br />additional dose of 0.2 mmol/kg BW may improve tumor characterisation and facilitate therapeutic<br />decision making.<br />Whole body MRI and Angiography<br />The recommended dose for intravenous injection is 0.1 mmol/kg BW (i.e. 0.2 ml/kg BW) to provide<br />diagnostically adequate contrast.<br />Angiography: In exceptional circumstances (e.g. failure to gain satisfactory images of an extensive<br />vascular territory) administration of a second consecutive injection of 0.1 mmol/kg BW, equivalent to<br />0.2 ml/kg BW may be justified. However, if the use of 2 consecutive doses of Dotagraf is anticipated<br />prior to commencing angiography, use of 0.05 mmol/kg BW, equivalent to 0.1 ml/kg BW for each<br />dose may be of benefit, depending on the imaging equipment available.<br />Special populations<br />Impaired renal function<br />The adult dose applies to patients with mild to moderate renal impairment (GFR &ge; 30 ml/min/1.73 m2).<br />Dotagraf should only be used in patients with severe renal impairment (GFR &lt; 30 ml/min/1.73 m2) and<br />in patients in the perioperative liver transplantation period after careful risk/benefit assessment and if<br />the diagnostic information is essential and not available with non-contrast enhanced MRI (see<br />section 4.4). If it is necessary to use Dotagraf, the dose should not exceed 0.1 mmol/kg body weight.<br />More than one dose should not be used during a scan. Because of the lack of information on repeated<br />administration, Dotagraf injections should not be repeated unless the interval between injections is at<br />least 7 days.<br />Elderly (aged 65 years and above)<br />No dosage adjustment is considered necessary. Caution should be exercised in elderly patients (see<br />section 4.4).<br />Impaired hepatic function<br />The adult dose applies to these patients. Caution is recommended, especially in the case of<br />perioperative liver transplantation period (see above impaired renal function).<br />Paediatric population<br />MRI of brain and spine / whole-body MRI: the recommended and maximum dose of Dotagraf is<br />0.1 mmol/kg BW. More than one dose should not be used during a scan.<br />Due to immature renal function in neonates up to 4 weeks of age and infants up to 1 year of age,<br />Dotagraf should only be used in these patients after careful consideration at a dose not exceeding<br />0.1 mmol/kg body weight. More than one dose should not be used during a scan. Because of the lack<br />of information on repeated administration, Dotagraf injections should not be repeated unless the<br />interval between injections is at least 7 days.<br />Dotagraf is not recommended for angiography in children under 18 years of age due to insufficient<br />data on efficacy and safety in this indication.<br />Method of administration<br />The product is indicated for intravenous administration only.<br /><br />Infusion rate: 3-5 ml/min (higher infusion rates up to 120 ml/min, i.e. 2 ml/sec, may be used for<br />angiographic procedures)<br />Optimal imaging: within 45 minutes after injection<br />Optimal image sequence: T1-weighted<br />Intravascular administration of contrast media should, if possible, be done with the patient lying<br />down. After the administration, the patient should be kept under observation for at least half an hour,<br />since experience shows that the majority of undesirable effects occur within this time.<br />Prepare a syringe with a needle. Remove the plastic disk. After cleaning the stopper with a pad<br />soaked in alcohol, puncture the stopper with the needle. Withdraw the quantity of product required<br />for the examination and inject it intravenously.<br />For single use only, any unused solution should be discarded.<br />The solution for injection should be inspected visually prior to use. Only clear solutions free of<br />visible particles should be used.<br />Paediatric population<br />Depending on the amount of Dotagraf to be given to the child, it is preferable to use Dotagraf vials<br />with a single use syringe of a volume adapted to this amount in order to have a better precision of the<br />injected volume.<br />In neonates and infants the required dose should be administered by hand.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to gadoteric acid, to meglumine or to any medicinal products containing gadolinium.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not use by intrathecal route. Take care to maintain strictly intravenous injection: extravasation<br />may result in local intolerance reactions, requiring the usual local care.<br />The usual precaution measures for MRI examination should be taken, such as exclusion of patients<br />with pacemakers, ferromagnetic vascular clips, infusion pumps, nerve stimulators, cochlear implants,<br />or suspected intracorporal metallic foreign bodies, particularly in the eye.<br />Hypersensitivity<br />&bull; As with other gadolinium containing contrast media, hypersensitivity reactions can occur,<br />including life-threatening (see section 4.8). Hypersensitivity reactions may be either allergic<br />(described as anaphylactic reactions when serious) or non allergic. They can be either<br />immediate (less than 60 minutes), or delayed (up to 7 days). Anaphylactic reactions occur<br />immediately and can be fatal. They are independent of the dose, can occur after even the first<br />dose of the product, and are often unpredictable.<br />&bull; There is always a risk of hypersensitivity regardless of the dose injected.<br />&bull; Patients who have already experienced a reaction during previous administration of a<br />gadolinium-containing MRI contrast agent present an increased risk of experiencing another<br />reaction on subsequent administration of the same product, or possibly other products, and are<br />therefore considered to be at high risk.<br />&bull; The injection of gadoteric acid may aggravate symptoms of an existing asthma. In patients with<br />asthma unbalanced by the treatment, the decision to use gadoteric acid must be made after<br />careful evaluation of the risk-benefit ratio.<br />&bull; As known from the use of iodinated contrast media, hypersensitivity reactions can be<br />aggravated in patients on beta-blockers, and particularly in the presence of bronchial asthma.<br />These patients may be refractory to standard treatment of hypersensitivity reactions with betaagonists.<br /><br />&bull; Before any contrast medium is injected, the patient should be questioned for a history of<br />allergy (e.g. seafood allergy, hay fever, hives), sensitivity to contrast media and bronchial<br />asthma as the reported incidence of adverse reactions to contrast media is higher in patients<br />with these conditions and premedication with antihistamines and/or glucocorticoids may be<br />considered.<br />&bull; During the examination, supervision by a physician is necessary. If hypersensitivity reactions<br />occur, administration of the contrast medium must be discontinued immediately and - if<br />necessary - specific therapy instituted. A venous access should thus be kept during the entire<br />examination. To permit immediate emergency countermeasures, appropriate drugs (e.g.<br />epinephrine and antihistamines), an endotracheal tube and a respirator should be ready at hand.<br />Impaired renal function<br />Prior to administration of Dotagraf, it is recommended that all patients are screened for renal<br />dysfunction by obtaining laboratory tests.<br />There have been reports of nephrogenic systemic fibrosis (NSF) associated with use of some<br />gadolinium- containing contrast agents in patients with acute or chronic severe renal impairment<br />(GFR &lt; 30 ml/min/1.73 m2). Patients undergoing liver transplantation are at particular risk since the<br />incidence of acute renal failure is high in this group. As there is a possibility that NSF may occur with<br />Dotagraf, it should therefore only be used in patients with severe renal impairment and in patients in<br />the perioperative liver transplantation period after careful risk/benefit assessment and if the diagnostic<br />information is essential and not available with non-contrast enhanced MRI.<br />Haemodialysis shortly after gadoteric acid administration may be useful at removing gadoteric acid<br />from the body. There is no evidence to support the initiation of haemodialysis for prevention or<br />treatment of NSF in patients not already undergoing haemodialysis.<br />Elderly<br />As the renal clearance of gadoteric acid may be impaired in the elderly, it is particularly important to<br />screen patients aged 65 years and older for renal dysfunction.<br />Paediatric population<br />Neonates and infants<br />Due to immature renal function in neonates up to 4 weeks of age and infants up to 1 year of age,<br />Dotagraf should only be used in these patients after careful consideration.<br />Cardiovascular disease<br />In patients with severe cardiovascular disease Dotagraf should only be administrated after careful risk<br />benefit assessment because only limited data are available so far.<br />CNS disorders<br />Like with other gadolinium containing contrast agents special precaution is necessary in patients with<br />a low threshold for seizures. Precautionary measures should be taken, e.g. close monitoring. All<br />equipment and drugs necessary to counter any convulsions which may occur must be made ready for<br />use beforehand.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interactions with other medicinal products have been observed. Formal drug interaction studies<br />have not been carried out.<br />Concomitant medications to be taken into account<br />Beta-blockers, vasoactive substances, angiotensin-converting enzyme inhibitors, angiotensin II<br />receptor antagonists: these medicinal products decrease the efficacy of the mechanisms of<br />cardiovascular compensation for blood pressure disorders: the radiologist must be informed before<br />injection of gadolinium complexes, and resuscitation equipment must be at hand.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are no data from the use of gadoteric acid in pregnant women. Animal studies do not indicate<br />direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). Gadoteric<br />acid crosses the placenta slowly. Dotagraf should not be used during pregnancy unless the clinical<br />condition of the woman requires use of gadoteric acid.<br />Breast-feeding<br />Gadolinium containing contrast agents are excreted into breast milk in very small amounts (see<br />section 5.3). At clinical doses, no effects on the infant are anticipated due to the small amount<br />excreted in milk and poor absorption from the gut. Continuing or discontinuing breast feeding for a<br />period of 24 hours after administration of Dotagraf, should be at the discretion of the doctor and<br />lactating mother</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. Ambulant<br />patients while driving vehicles or operating machinery should take into account that nausea may<br />incidentally occur</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects in association with the use of gadoteric acid are usually mild to moderate in intensity and<br />transient in nature. Injection site reactions, nausea and headaches are the most frequently observed<br />reactions.<br />During clinical trials, nausea, headache, injection site reactions, feeling cold, hypotension,<br />somnolence, dizziness, feeling hot, burning sensation, rash, asthenia, dysgeusia and hypertension<br />were the most frequent, uncommonly observed (&ge;1/1,000 to &lt;1/100) related adverse events.<br />Since post-marketing, the most commonly reported adverse reactions following administration of<br />gadoteric acid are nausea, vomiting, pruritus and hypersensitivity reactions.<br />In hypersensitivity reactions, the reactions most frequently observed are skin reactions, which can be<br />localized, extended or generalized.<br />These reactions occur most often immediately (during the injection or within one hour after the start<br />of injection) or sometimes delayed (one hour to several days after injection), presenting as skin<br />reactions in this case.<br />Immediate reactions include one or more effects, which appear simultaneously or sequentially, which<br />are most often cutaneous, respiratory, gastrointestinal, articular and/or cardiovascular reactions. Each<br />sign may be a warning sign of a starting shock and leads very rarely to death.<br />Isolated cases of nephrogenic systemic fibrosis (NSF) have been reported with gadoteric acid, most<br />of which were in patients co-administered other gadolinium-containing contrast agents (see<br />section 4.4).<br />The adverse reactions are listed in the table below by SOC (System Organ Class) and by frequency<br />with the following guidelines: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon<br />(&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be<br />estimated from the available data). The data presented are from clinical trials involving 2822 patients<br />when available, or from a pool of observational studies involving 185,500 patients</p><p><img alt="" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>&nbsp;</p><p>Adverse reaction in Children<br />Safety of paediatric patients was considered in clinical trials and postmarketing studies. As compared<br />to adult, the safety profile of gadoteric acid did not show any specificity in children. Most of<br />reactions are gastrointestinal symptoms or signs of hypersensitivity.<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It<br />allows continued monitoring of the benefit/risk balance of the medicinal product.<br />To report any side effect(s):<br />The National Pharmacovigilance Centre (NPC).<br />Fax: +966-11-205-7662<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gadoteric acid can be removed by haemodialysis. However there is no evidence that haemodialysis<br />is suitable for prevention of nephrogenic systemic fibrosis (NSF).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: paramagnetic contrast media<br />ATC code: V08CA02 (gadoteric acid).<br />Dotagraf is a paramagnetic contrast agent for magnetic resonance imaging. The contrast-enhancing<br />effect is mediated by gadoteric acid which is a ionic gadolinium complex composed out of<br />Gadolinium oxide and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and<br />present as meglumine salt.<br />The paramagnetic effect (relaxivity) is determined from the effect on spin-lattice relaxation time<br />(T1) about 3.4 mmol-1 &middot; L &middot;sec-1 and on the spin-spin relaxation time (T2) about 4.27 mmol-1 &middot; L&middot;<br />sec-1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After intravenous administration gadoteric acid is quickly distributed in the extracellular fluids. The<br />distribution volume was approx. 18 l which is approximately equal to the volume of extra-cellular<br />fluid. Gadoteric acid does not bind to proteins like serum albumin.<br />Gadoteric acid is eliminated rapidly (89 % after 6 h, 95 % after 24 h) in unchanged form through the<br />kidneys by glomerular filtration. Excretion via the feces is negligible. No metabolites were detected.<br />The elimination half life amounts to about 1.6 hours in patients with a normal renal function. In<br />renally impaired patients, the elimination half life was increased to approximately 5 hours for a<br />creatinine clearance between 30 and 60 ml/min and approximately 14 hours for a creatinine clearance<br />between 10 and 30 ml/min.<br />In animal experiments it has been demonstrated that gadoteric acid can be removed by dialysis</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity, genotoxicity or toxicity to reproduction.<br />Animal studies have shown negligible (less than 1 % of the administered dose) secretion of gadoteric<br />acid in maternal milk</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Meglumine<br />1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)<br />Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other<br />medicinal products</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
Chemical and physical in-use stability has been demonstrated for 72 hours at room temperature. From
a microbiological point of view, the product should be used immediately. If not used immediately, inuse
storage times and conditions prior to use are the responsibility of the user and would normally not
be longer than 24 hours at 2 to 8 °C, unless opening has taken place in controlled and validated
aseptic conditions.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 and 10 Type II single-use colourless glass vials of 10 ml and 20 ml (filled to 15 or 20 ml), sealed<br />with a stopper of bromobutyl rubber and packed in unit carton box.<br />Not all pack sizes may be marketed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The peel-off tracking label on the vials should be stuck onto the patient record to enable accurate<br />recording of the gadolinium contrast agent used. The dose used should also be recorded. If electronic<br />patient records are used, the name of the product, the batch number and the dose should be entered<br />into the patient record.<br />Any unused medicinal product or waste material should be disposed of in accordance with local<br />requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bayer AG
Kaiser-Wilhelm-Allee 1
51373 Leverkusen, Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>